Researchers found that the Plasmodiumparasites responsible for malaria rely on human liver cell protein for their development into an infectious form.
While fewer people are dying from malaria In Africa overall, cases have not decreased. And in parts of Asia drug-resistant strains of malaria have stated to appear.
Research demonstrated that a naturally occurring fungus engineered to deliver a toxin to mosquitoes safely reduced mosquito populations by more than 99 percent in a simulated village setting in Burkina Faso.
After last reporting a malaria case in 2013, Algeria joined 37 other countries that have been certified malaria-free by the World Health Organization (WHO).
The new vaccine took 32 years of research, and cost more than $700 million has been shown to be 40 percent effective at preventing the disease over four years.
When compared to the current process, the new process reduces the time it takes to produce artemisinin concentrate is reduced by 87.5 percent.
The urban malaria vector Anopheles stephensi recently invaded Djibouti and Ethiopia, potentially spreading to other areas of Africa.
An effort to make malaria data available to health workers in Zambia has helped the country to reduce deaths from the disease by 92 percent in the southern region.
Over the next four years, the experiences of these countries will help the WHO determine if RTS,S can be effectively used, and whether it will deliver the nearly 40 percent decrease in malaria infections seen in an earlier Phase 3 clinical trial.To see whether a new malaria vaccine, RTS, is effective, the World Health Organization (WHO) and partners have devised a limited rollout of the vaccine in Malawi followed by Ghana and Kenya.
Researchers demonstrated that mass drug administration can grant community-level protection against Plasmodium falciparum malaria.